Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


podcastingtoday.co.uk > graeme-sutherland-launches-the-long-goodbye-podcast

Graeme Sutherland launches The Long Goodbye podcast

10+ hour ago   (216+ words) A new podcast is launching to provide support and understanding for families affected by Alzheimer’s disease and dementia. Graeme Sutherland, a media influencer and content creator, is launching The Long Goodbye, a series inspired by his own family’s experience after…...


healio.com > hematology%20oncology

Hematology & Oncology News - Healio

5+ hour, 12+ min ago   (275+ words) HemOnc Today - Find hematology and oncology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles from the #1 online source for hematologists and oncologists, HemOnc Today. Veterans with melanoma may face higher risk for Parkinson’s…...


yahoo.com > news > videos > runners-raise-money-children-cancer-035708886.html

Runners raise money for children with cancer on East Bay Bike Path

13+ hour, 50+ min ago   (33+ words) Yahoo Hundreds of runners took to the East Bay Bike Path on Saturday for the Mark Palumbo Memorial University Orthopedics 5K....


natlawreview.com > press-releases > enhertur-demonstrated-median-progression-free-survival-143-months-first-line

Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial

14+ hour, 10+ min ago   (848+ words) Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). In the primary endpoint analysis, Enhertu monotherapy significantly reduced…...


greenocktelegraph.co.uk > news > 26529930.new-unit-childrens-hospital-molly-cuddihys-name

New palliative care unit for children to be set up in memory of Gourock campaigner

12+ hour, 17+ min ago   (694+ words) A GROUND-BREAKING new unit to care for children with terminal illnesses is to be set up in the name of incredible Gourock campaigner Molly Cuddihy a year after her death. Molly's Suite is a palliative care hub to be created…...


miragenews.com > enhertu-shows-14-3-month-pfs-in-her2-lung-1743475

Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial

12+ hour, 25+ min ago   (338+ words) Results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, South Korea (abstract #PL03.08). In the primary endpoint of PFS, Enhertu monotherapy…...


hellocare.com.au > holistic-palliative-care-is-in-the-conversations-of-dying-well

Holistic palliative care is in the conversations of dying well

15+ hour, 29+ min ago   (1807+ words) Vandersman didn’t come to palliative care from arm’s length. It was her top pick. “Palliative care was my first choice in my RN graduate program, other staff were astonished, ‘you could have done theatre or ICU?’” “In the culture I…...


asbmb.org > asbmb-today > people > 091426 > lillian-brady-receives-mcknight-scholar-award

Lillian Brady receives McKnight Scholar Award

12+ hour, 31+ min ago   (287+ words) Lillian Brady was selected to receive a 2026 McKnight Scholar Award from The McKnight Endowment Fund for Neuroscience. The award recognizes early-career scientists who are establishing independent research programs and advancing neuroscience. The McKnight Scholar Awards have supported innovative neuroscience investigators…...


miragenews.com > tagrisso-achieves-8-year-survival-in-egfr-lung-1743462

Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer

12+ hour, 39+ min ago   (499+ words) These results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, Republic of Korea (Abstract PL03.01). These data were also simultaneously published…...